Former CEO of Siemens Healthcare Brings Broad Executive Experience to
Board
BILLERICA, Mass.--(BUSINESS WIRE)--
Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed
Dr. Hermann Requardt to its Board of Directors effective immediately.
Dr. Requardt will serve for an initial term expiring at the Company’s
2017 Annual Meeting of Stockholders.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20150807005747/en/
Dr. Hermann Requardt, former CEO of Siemens Healthcare, joins Bruker Corp.'s Board of Directors (Photo: Business Wire)
Dr. Requardt currently serves as an independent strategic advisor to a
number of European public and private life science and healthcare
technology companies. From 2009 to February 2015, he served as Chief
Executive Officer of the healthcare division of Siemens AG.
He has also served as Chief Technology Officer of Siemens AG from 2008
through 2011. Additionally, from 2006 through January 2015 he was a
member of the Siemens AG Managing Board, during which time he also held
a variety of regional and operational responsibilities at Siemens and
its affiliates. Dr. Requardt joined Siemens Medical Solutions in 1984
and served there in roles of increasing responsibility before assuming
global responsibility for the magnetic resonance business unit in 1994.
Dr. Requardt is an honorary Professor of Physics at the University of
Frankfurt and serves on several academic and industrial boards in
Germany, including, among other positions, serving as Vice Chairman of
Fraunhofer Gesellschaft, Europe’s largest application-oriented research
organization, and as a member of the Executive Board of Acatech, the
German National Academy of Science and Engineering. He also is a member
of the Advisory Board of Dekra SE, and the Supervisory Board of Sivantos
Group, which was Siemens Audiology Solutions prior to its spin-off in
early 2015. Dr. Requardt holds a Ph.D. in Biophysics, with a focus on
radiation biophysics and microbiology, from the University of Frankfurt.
"My relationship with Bruker goes back for decades. As a scientist, I
loved their products, and as a manager, I enjoyed their collaboration
culture and their business ethics. I am proud and happy to finally
become a member of the team,” said Herman Requardt.
Frank Laukien, President & CEO of Bruker, stated: “We are truly
delighted to have Dr. Requardt join our Board of Directors. Hermann’s
stellar business and executive track record, in combination with his
broad experience in healthcare, and in-depth insights into preclinical
imaging, molecular diagnostics and microbiology will allow him to make
immediate, positive contributions to Bruker.”
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve the
quality of human life. Bruker’s high-performance scientific research
instruments and high-value analytical solutions enable scientists to
explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation,
productivity and customer success in life science molecular research, in
applied and pharma applications, and in microscopy, nano-analysis and
industrial applications, as well as in cell biology, preclinical
imaging, clinical research, microbiology and molecular diagnostics. For
more information, please visit: http://www.bruker.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150807005747/en/
Source: Bruker Corporation